Enhancement of the systemic and CNS specific delivery of L-dopa by the nasal administration of its water soluble prodrugs (Q73070851)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11028945%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Enhancement of the systemic and CNS specific delivery of L-dopa by the nasal administration of its water soluble prodrugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11028945%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

H D Kao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11028945%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A Traboulsi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11028945%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

S Itoh

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11028945%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

L Dittert

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11028945%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A Hussain

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11028945%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 August 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11028945%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

published in

Pharmaceutical Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11028945%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11028945%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11028945%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

978-984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11028945%20AND%20SRC:MED&resulttype=core&format=json

Improved delivery through biological membranes. 4. Prodrugs of L-dopa

1 November 2019

cites work

1 reference

12 December 2020

High-performance liquid chromatography with amperometric detection of plasma L-3,4-dihydroxyphenylalanine in Parkinsonian patients

1 reference

12 December 2020

Levodopa pharmacokinetics and pharmacodynamics in fluctuating parkinsonian patients

1 reference

12 December 2020

Control of on/off phenomenon by continuous intravenous infusion of levodopa

1 reference

12 December 2020

Treatment of chronic Parkinson's disease with controlled-release carbidopa/levodopa.

1 reference

12 December 2020

Distribution of antihistamines into the CSF following intranasal delivery

1 reference

12 December 2020

Short-chain alkyl esters of L-dopa as prodrugs for rectal absorption

1 reference

12 December 2020

The Transport of a Drug to the Cerebrospinal Fluid Directly from the Nasal Cavity: The Relation to the Lipophilicity of the Drug

1 reference

12 December 2020

Mechanism of nasal absorption of drugs. IV: Plasma levels of radioactivity following intranasal administration of [3H]leucine enkephalin

1 reference

12 December 2020

Nasal absorption of propranolol from different dosage forms by rats and dogs

1 reference

12 December 2020

Pathogenesis of viral infections of the nervous system

1 reference

12 December 2020

A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines

1 reference

12 December 2020

Clinical pharmacokinetics of anti-parkinsonian drugs

1 reference

12 December 2020

L-dopa esters as potential prodrugs: behavioural activity in experimental models of Parkinson's disease

1 reference

12 December 2020

Intranasal drug delivery

1 reference

12 December 2020

Dosage form design for improvement of bioavailability of levodopa IV: Possible causes of low bioavailability of oral levodopa in dogs

1 reference

12 December 2020

Dosage form design for improvement of bioavailability of levodopa III: Influence of dose on pharmacokinetic behavior of levodopa in dogs and Parkinsonian patients

1 reference

12 December 2020

Dosage form Design for Improvement of Bioavailability of Levodopa V: Absorption and Metabolism of Levodopa in Intestinal Segments of Dogs

1 reference

12 December 2020

Experimental Investigations on the Penetration of198Au from Nasal Mucous Membrane into Cerebrospinal Fluid

1 reference

12 December 2020

On-off fluctuations in Parkinson's disease. A clinical and neuropharmacological study.

1 reference

12 December 2020

Mechanism of nasal absorption of drugs. II: Absorption of L-tyrosine and the effect of structural modification on its absorption

1 reference

12 December 2020

The effect of carbidopa on the pharmacokinetics of intravenously administered levodopa: the mechanism of action in the treatment of parkinsonism.

1 reference

12 December 2020

Pharmacokinetics of progesterone after its administration to ovariectomized rhesus monkeys by injection, infusion, or nasal spraying

1 reference

12 December 2020

Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1007583422634

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11028945%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference